首页 › 基金 › Kedalion Capital Management LLP › ABUS
Kedalion Capital Management LLP 对 ABUS 的持仓历史
ARBUTUS BIOPHARMA CORP · 医疗保健
Kedalion Capital Management LLP 在 Q3 2026 的 13F 申报中披露持有 ABUS(ARBUTUS BIOPHARMA CORP)20,168 股,市值约 US$96K,约占其申报组合的 0.00%,在其申报持仓中市值排名第 5 位。 Kedalion Capital Management LLP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-06 · 来源: SEC EDGAR Form 13F-HR
Kedalion Capital Management LLP 对 ABUS 的持仓演变
Kedalion Capital Management LLP 于 Q3 2026 首次披露 ABUS 持仓:20,168 股(约 US$96K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 20.17K | $96.40K | 新进 |
关于 ABUS 与 13F 数据
ABUS(ARBUTUS BIOPHARMA CORP)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 ABUS,申报仓位最大的包括:Whitefort Capital Management, LP (US$75.8M), Two Seas Capital LP (US$38.9M), BlackBarn Capital Partners LP (US$12.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ABUS 的基金
- Whitefort Capital Management, LP 15.79M 股 · $75.81M · Q2 2026
- Two Seas Capital LP 8.14M 股 · $38.93M · Q3 2026
- BlackBarn Capital Partners LP 2.50M 股 · $12.00M · Q2 2026
- Deltroit Asset Management (UK) LLP 1.20M 股 · $5.76M · Q2 2026
- Western Standard LLC 542.79K 股 · $2.61M · Q2 2026
- Rangeley Capital, LLC 500.00K 股 · $2.40M · Q2 2026
更多关于 Kedalion Capital Management LLP
常见问题
How long has Kedalion Capital Management LLP held ABUS?
Kedalion Capital Management LLP has disclosed ABUS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Kedalion Capital Management LLP's current position in ABUS?
As of Q3 2026, Kedalion Capital Management LLP holds 20.17K shares of ABUS (ARBUTUS BIOPHARMA CORP), valued at $96.40K, representing 0.00% of its reported portfolio and ranking #5.
Has Kedalion Capital Management LLP been buying or selling ABUS?
In the latest 13F filing (Q3 2026), Kedalion Capital Management LLP newly opened its position in ABUS.
Which other funds hold ABUS?
Other major institutional holders of ABUS include Whitefort Capital Management, LP, Two Seas Capital LP, BlackBarn Capital Partners LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.